For citations:
Tarlovskaya E.I., Nechaeva G.I., Malchikova S.V., Semenkin А.А. PREDICTION OF THE INFLUENCE OF ORIGINAL AND GENERIC ROSUVASTATIN ON DIRECT MEDICAL COSTS OF SECONDARY PREVENTION IN PATIENTS WITH CHRONIC TYPES OF ISCHEMIC HEART DISEASE. Cardiovascular Therapy and Prevention. 2015;14(4):29-37. (In Russ.) https://doi.org/10.15829/1728-8800-2015-4-29-37